Front. Oncol. Frontiers in Oncology Front. Oncol. 2234-943X Frontiers Media S.A. 10.3389/fonc.2024.1372295 Oncology Correction Corrigendum: Bevacizumab-Irinotecan combination therapy in recurrent low-grade glioma, previously treated with chemo-radiotherapy: a case report Castelli Barbara 1 2 * Fonte Carla 2 Guidi Milena 1 2 Tellini Marco 2 Di Nicola Marco 2 Iacono Alessandro 3 Buccoliero Anna Maria 4 Greto Daniela 5 Genitori Lorenzo 6 Sardi Iacopo 2 1 Health Sciences Department, University of Florence, Florence, Italy 2 Neuro-Oncology Unit, Meyer Children’s Hospital IRCCS, Florence, Italy 3 Radiology Unit, Meyer Children’s Hospital IRCCS, Florence, Italy 4 Pathology Unit, Meyer Children’s Hospital IRCCS, Florence, Italy 5 Radiotherapy Unit, University of Florence, Florence, Italy 6 Neurosurgery Unit, Meyer Children’s Hospital IRCCS, Florence, Italy

Approved by: Frontiers Editorial Office, Frontiers Media SA, Switzerland

*Correspondence: Barbara Castelli, barbara.castelli@meyer.it

01 02 2024 2024 14 1372295 17 01 2024 19 01 2024 Copyright © 2024 Castelli, Fonte, Guidi, Tellini, Di Nicola, Iacono, Buccoliero, Greto, Genitori and Sardi 2024 Castelli, Fonte, Guidi, Tellini, Di Nicola, Iacono, Buccoliero, Greto, Genitori and Sardi

This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

 A Corrigendum on Bevacizumab-Irinotecan combination therapy in recurrent low-grade glioma, previously treated with chemo-radiotherapy: a case report. By Castelli B, Fonte C, Guidi M, Tellini M, Di Nicola M, Iacono A, Buccoliero AM, Greto D, Genitori L and Sardi I (2023) Front. Oncol. 13:1244628. doi: 10.3389/fonc.2023.1244628 low-grade gliomas bevacizumab irinotecan pilocytic astrocytoma case report section-in-acceptance Neuro-Oncology and Neurosurgical Oncology

In the published article, there was an error in affiliations 2,3,4,6. Instead of “Meyer Children’s Hospital Scientific Institute for Research, Hospitalization and Healthcare (IRCCS),” it should be “Meyer Children’s Hospital IRCCS.”

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.